Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers
Although curable, leprosy requires better diagnostic and prognostic tools to accompany therapeutic strategies. We evaluated the serum samples of leprosy patients from Venezuela and Brazil for reactivity against the specific recombinant proteins, ML0405 and ML2331, and the LID-1 fusion protein that i...
Saved in:
| Published: |
2011
|
|---|---|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10872/12999 |
| Tags: |
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!